Clinical trial
Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or…
NCT00094835 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00094835 |
|---|---|
| Title | Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) |
| Official title | An Open-label, Dose-finding Study to Evaluate the Safety and Pharmacokinetics (PK) of AMG 706 With Carboplatin/Paclitaxel, AMG 706 With Panitumumab and AMG 706 With Panitumumab and Carboplatin/Paclitaxel in the Treatment of Subjects With Advanced Non-Small Cell Lung Cancer (NSCLC) |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer, Non-Small Cell Lung Cancer |
| Intervention type | Biological, Drug |
| Interventions | Panitumumab, Motesanib diphosphate, Paclitaxel, Carboplatin |
| Enrollment | 51 |
| Start date | Jan 1, 2005 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Oct 27, 2004 |
| Last update posted | Mar 24, 2016 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: